289 related articles for article (PubMed ID: 32369604)
1. Internationalization of read-across as a validated new approach method (NAM) for regulatory toxicology.
Rovida C; Barton-Maclaren T; Benfenati E; Caloni F; Chandrasekera PC; Chesné C; Cronin MTD; De Knecht J; Dietrich DR; Escher SE; Fitzpatrick S; Flannery B; Herzler M; Hougaard Bennekou S; Hubesch B; Kamp H; Kisitu J; Kleinstreuer N; Kovarich S; Leist M; Maertens A; Nugent K; Pallocca G; Pastor M; Patlewicz G; Pavan M; Presgrave O; Smirnova L; Schwarz M; Yamada T; Hartung T
ALTEX; 2020; 37(4):579-606. PubMed ID: 32369604
[TBL] [Abstract][Full Text] [Related]
2. Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience.
Moné MJ; Pallocca G; Escher SE; Exner T; Herzler M; Bennekou SH; Kamp H; Kroese ED; Leist M; Steger-Hartmann T; van de Water B
Arch Toxicol; 2020 Oct; 94(10):3581-3592. PubMed ID: 32886186
[TBL] [Abstract][Full Text] [Related]
3. Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project.
Escher SE; Kamp H; Bennekou SH; Bitsch A; Fisher C; Graepel R; Hengstler JG; Herzler M; Knight D; Leist M; Norinder U; Ouédraogo G; Pastor M; Stuard S; White A; Zdrazil B; van de Water B; Kroese D
Arch Toxicol; 2019 Dec; 93(12):3643-3667. PubMed ID: 31781791
[TBL] [Abstract][Full Text] [Related]
4. NAM-supported read-across: From case studies to regulatory guidance in safety assessment.
Rovida C; Escher SE; Herzler M; Bennekou SH; Kamp H; Kroese DE; Maslankiewicz L; Moné MJ; Patlewicz G; Sipes N; Van Aerts L; White A; Yamada T; Van de Water B
ALTEX; 2021; 38(1):140-150. PubMed ID: 33452529
[TBL] [Abstract][Full Text] [Related]
5. A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment.
Alexander-White C; Bury D; Cronin M; Dent M; Hack E; Hewitt NJ; Kenna G; Naciff J; Ouedraogo G; Schepky A; Mahony C; Europe C
Regul Toxicol Pharmacol; 2022 Mar; 129():105094. PubMed ID: 34990780
[TBL] [Abstract][Full Text] [Related]
6. Automated integration of structural, biological and metabolic similarities to improve read-across.
Gadaleta D; Golbamaki Bakhtyari A; Lavado GJ; Roncaglioni A; Benfenati E
ALTEX; 2020; 37(3):469-481. PubMed ID: 32388568
[TBL] [Abstract][Full Text] [Related]
7. Read-across approaches: current applications and regulatory acceptance in Korea, Japan, and China.
Lee BM; Lee SH; Yamada T; Park S; Wang Y; Kim KB; Kwon S
J Toxicol Environ Health A; 2022 Mar; 85(5):184-197. PubMed ID: 34670481
[TBL] [Abstract][Full Text] [Related]
8. Relevance and Application of Read-Across - Mini Review of European Consensus Platform for Alternatives and Scandinavian Society for Cell Toxicology 2017 Workshop Session.
Stuard SB; Heinonen T
Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():37-41. PubMed ID: 29524304
[TBL] [Abstract][Full Text] [Related]
9. Toward Good Read-Across Practice (GRAP) guidance.
Ball N; Cronin MT; Shen J; Blackburn K; Booth ED; Bouhifd M; Donley E; Egnash L; Hastings C; Juberg DR; Kleensang A; Kleinstreuer N; Kroese ED; Lee AC; Luechtefeld T; Maertens A; Marty S; Naciff JM; Palmer J; Pamies D; Penman M; Richarz AN; Russo DP; Stuard SB; Patlewicz G; van Ravenzwaay B; Wu S; Zhu H; Hartung T
ALTEX; 2016; 33(2):149-66. PubMed ID: 26863606
[TBL] [Abstract][Full Text] [Related]
10. Read-across approaches--misconceptions, promises and challenges ahead.
Patlewicz G; Ball N; Becker RA; Booth ED; Cronin MT; Kroese D; Steup D; van Ravenzwaay B; Hartung T
ALTEX; 2014; 31(4):387-96. PubMed ID: 25368965
[TBL] [Abstract][Full Text] [Related]
11. Incorporating integrated testing strategy (ITSv1) defined approach into read-across (RAx) in predicting skin sensitization potency: ITSv1-based RAx.
Nakayama K; Zifle A; Fritz S; Fuchs A; Sakaguchi H; Miyazawa M
Regul Toxicol Pharmacol; 2023 Mar; 139():105358. PubMed ID: 36805910
[TBL] [Abstract][Full Text] [Related]
12. The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods.
Krebs A; van Vugt-Lussenburg BMA; Waldmann T; Albrecht W; Boei J; Ter Braak B; Brajnik M; Braunbeck T; Brecklinghaus T; Busquet F; Dinnyes A; Dokler J; Dolde X; Exner TE; Fisher C; Fluri D; Forsby A; Hengstler JG; Holzer AK; Janstova Z; Jennings P; Kisitu J; Kobolak J; Kumar M; Limonciel A; Lundqvist J; Mihalik B; Moritz W; Pallocca G; Ulloa APC; Pastor M; Rovida C; Sarkans U; Schimming JP; Schmidt BZ; Stöber R; Strassfeld T; van de Water B; Wilmes A; van der Burg B; Verfaillie CM; von Hellfeld R; Vrieling H; Vrijenhoek NG; Leist M
Arch Toxicol; 2020 Jul; 94(7):2435-2461. PubMed ID: 32632539
[TBL] [Abstract][Full Text] [Related]
13. Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk.
Daneshian M; Kamp H; Hengstler J; Leist M; van de Water B
Arch Toxicol; 2016 May; 90(5):1021-4. PubMed ID: 27017488
[TBL] [Abstract][Full Text] [Related]
14. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
[TBL] [Abstract][Full Text] [Related]
15. New approach methodologies (NAMs) for human-relevant biokinetics predictions. Meeting the paradigm shift in toxicology towards an animal-free chemical risk assessment.
Punt A; Bouwmeester H; Blaauboer BJ; Coecke S; Hakkert B; Hendriks DFG; Jennings P; Kramer NI; Neuhoff S; Masereeuw R; Paini A; Peijnenburg AACM; Rooseboom M; Shuler ML; Sorrell I; Spee B; Strikwold M; Van der Meer AD; Van der Zande M; Vinken M; Yang H; Bos PMJ; Heringa MB
ALTEX; 2020; 37(4):607-622. PubMed ID: 32521035
[TBL] [Abstract][Full Text] [Related]
16. Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice.
Spielmann H; Liebsch M
Toxicol In Vitro; 2001; 15(4-5):585-90. PubMed ID: 11566595
[TBL] [Abstract][Full Text] [Related]
17. Toxicology testing steps towards computers.
Kling J
Lab Anim (NY); 2019 Feb; 48(2):40-42. PubMed ID: 30643278
[No Abstract] [Full Text] [Related]
18. Incorporating lines of evidence from New Approach Methodologies (NAMs) to reduce uncertainties in a category based read-across: A case study for repeated dose toxicity.
Pestana CB; Firman JW; Cronin MTD
Regul Toxicol Pharmacol; 2021 Mar; 120():104855. PubMed ID: 33359265
[TBL] [Abstract][Full Text] [Related]
19. In vitro tests within the REACH information strategies.
Louekari K; Sihvonen K; Kuittinen M; Sømnes V
Altern Lab Anim; 2006 Aug; 34(4):377-86. PubMed ID: 16945005
[TBL] [Abstract][Full Text] [Related]
20. Workshop on the validation and regulatory acceptance of innovative 3R approaches in regulatory toxicology - Evolution versus revolution.
Burgdorf T; Piersma AH; Landsiedel R; Clewell R; Kleinstreuer N; Oelgeschläger M; Desprez B; Kienhuis A; Bos P; de Vries R; de Wit L; Seidle T; Scheel J; Schönfelder G; van Benthem J; Vinggaard AM; Eskes C; Ezendam J
Toxicol In Vitro; 2019 Sep; 59():1-11. PubMed ID: 30946968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
